Based on the Fortrea Holdings Inc. stock forecast from 6 analysts, the average analyst target price for Fortrea Holdings Inc. is USD 38.86 over the next 12 months. Fortrea Holdings Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Fortrea Holdings Inc. is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Fortrea Holdings Inc.’s stock price was USD 37.41. Fortrea Holdings Inc.’s stock price has changed by +2.92% over the past week, -1.66% over the past month and 0% over the last year.
No recent analyst target price found for Fortrea Holdings Inc.
No recent average analyst rating found for Fortrea Holdings Inc.
Company Overview Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Read Less
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services se...Read More
Frequently Asked Questions About Fortrea Holdings Inc. (FTRE) Stock
Based on ratings from 6 analysts Fortrea Holdings Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 5 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on FTRE's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for FTRE is USD 38.86 over the next 12 months. The maximum analyst target price is USD 44 while the minimum anlayst target price is USD 35.
FTRE stock's Price/Earning ratio is 467.67.
Our analysis grades FTRE stock's Price / Earning ratio at F. This means that FTRE stock's Price/Earning ratio is above 97% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this FTRE may be a overvalued for its sector.
The last closing price of FTRE's stock was USD 37.41.
The most recent market capitalization for FTRE is USD 2.49B.
Based on targets from 6 analysts, the average taret price for FTRE is projected at USD 38.86 over the next 12 months.
This means that FTRE's stock price may go up by +3.87% over the next 12 months.
Following are ETFs with the highest allocation to Fortrea Holdings Inc.'s stock :
As per our most recent records Fortrea Holdings Inc. has 17,460 Employees.
Fortrea Holdings Inc.'s registered address is 8 Moore Drive, Durham, NC, United States, 27709.
You can get more information about it from Fortrea Holdings Inc.'s website at https://www.fortrea.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FTRE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
